{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:02:55Z","timestamp":1756425775508,"version":"3.44.0"},"reference-count":37,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DTB"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:p>In last month's issue, we discussed drug treatment for acute mood episodes (mania, hypomania, depression or mixed states) in patients with bipolar disorder.1 We pointed out that prescribers have to keep in mind that patients will often need treatment long term. Here we consider the role of drug therapy for maintenance and prevention in patients with bipolar disorder. We also discuss some common clinical situations that pose particular problems and dilemmas with regard to drug treatment.<\/jats:p>","DOI":"10.1136\/dtb.2005.43533","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T16:15:40Z","timestamp":1216397740000},"page":"33-37","source":"Crossref","is-referenced-by-count":5,"title":["Drug treatments for bipolar disorder: 2 - Maintenance, prevention and special situations"],"prefix":"10.1136","volume":"43","member":"239","published-online":{"date-parts":[[2005,5,1]]},"reference":[{"key":"2025082800182475000_43.5.33.1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/dtb.2005.43428","article-title":"Drug treatments for bipolar disorder: 1 - Acute manic or depressive episodes","volume":"43","year":"2005","journal-title":"DTB"},{"key":"2025082800182475000_43.5.33.2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0006-3223(00)00909-4","article-title":"Historical perspectives and natural history of bipolar disorder","volume":"48","author":"Angst","year":"2000","journal-title":"Biol Psychiatry"},{"key":"2025082800182475000_43.5.33.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00909-4"},{"key":"2025082800182475000_43.5.33.4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.1"},{"key":"2025082800182475000_43.5.33.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(00)00310-4"},{"key":"2025082800182475000_43.5.33.6","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103017002003"},{"key":"2025082800182475000_43.5.33.7","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.6.530"},{"key":"2025082800182475000_43.5.33.8","unstructured":"Goodwin FK Jamison KR . Manic-depressive illness New York: Oxford University Press 1990 127\u201356."},{"key":"2025082800182475000_43.5.33.9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1034\/j.1600-0447.2001.00464.x","article-title":"Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis","volume":"104","author":"Tondo","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"2025082800182475000_43.5.33.10","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2001.00464.x"},{"key":"2025082800182475000_43.5.33.11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"2025082800182475000_43.5.33.12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4088\/JCP.v65n0321","article-title":"A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar 1 disorder","volume":"65","author":"Goodwin","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"2025082800182475000_43.5.33.13","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0321"},{"key":"2025082800182475000_43.5.33.14","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.178.41.s184"},{"key":"2025082800182475000_43.5.33.15","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.2.149"},{"key":"2025082800182475000_43.5.33.16","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.5.481"},{"key":"2025082800182475000_43.5.33.17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-199812000-00007","article-title":"Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder","volume":"18","author":"Greil","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"2025082800182475000_43.5.33.18","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00007"},{"key":"2025082800182475000_43.5.33.19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"2025082800182475000_43.5.33.20","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.4.392"},{"key":"2025082800182475000_43.5.33.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-2406.2003.00060.x"},{"key":"2025082800182475000_43.5.33.22","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","article-title":"Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study","volume":"160","author":"Tohen","year":"2003","journal-title":"Am J Psychiatry"},{"key":"2025082800182475000_43.5.33.23","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.7.1263"},{"key":"2025082800182475000_43.5.33.24","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0116"},{"key":"2025082800182475000_43.5.33.25","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1176\/ajp.156.8.1164","article-title":"Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania","volume":"156","author":"Suppes","year":"1999","journal-title":"Am J Psychiatry"},{"key":"2025082800182475000_43.5.33.26","unstructured":"Tohen M . A randomized, placebo-controlled 12-month trial of olanzapine in patients in remission from bipolar I disorder Arch Gen Psychiatry In press."},{"key":"2025082800182475000_43.5.33.27","unstructured":"Tohen M . Olanzapine versus lithium in relapse\/recurrence prevention in bipolar disorder: a randomized double-blind controlled 12-month clinical trial Am J Psychiatry In press."},{"key":"2025082800182475000_43.5.33.28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1192\/bjp.184.4.337","article-title":"Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone","volume":"184","author":"Tohen","year":"2004","journal-title":"Br J Psychiatry"},{"key":"2025082800182475000_43.5.33.29","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.4.337"},{"key":"2025082800182475000_43.5.33.30","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0807"},{"key":"2025082800182475000_43.5.33.31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4088\/JCP.v58n1102","article-title":"Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder","volume":"58","author":"Denicoff","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"2025082800182475000_43.5.33.32","unstructured":"Carson GA . Bipolar disorder Martin A . Pediatric Psychopharmacology. Principles and Practice New York: Oxford University Press 2003."},{"key":"2025082800182475000_43.5.33.33","doi-asserted-by":"crossref","unstructured":"Davanzo P McCracken J . Mood stabilizers: lithium and anticonvulsants Martin A . Pediatric Psychopharmacology. Principles and Practice New York: Oxford University Press 2003.","DOI":"10.1093\/oso\/9780195141733.003.0025"},{"key":"2025082800182475000_43.5.33.34","unstructured":"Committee on Safety of Medicines. 2004 Report of the CSM Expert Working Group on the safety of selective serotonin reuptake inhibitor antidepressants [online]. Available: http:\/\/medicines.mhra.gov.uk\/ourwork\/monitorsafequalmed\/safetymessages\/SSRIfinal.pdf [Accessed 20 April 2005]."},{"key":"2025082800182475000_43.5.33.35","first-page":"42","article-title":"The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics","volume":"63","author":"Ernst","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"2025082800182475000_43.5.33.36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/dtb.2005.43213","article-title":"Antiepileptics, pregnancy and the child","volume":"43","year":"2005","journal-title":"DTB"},{"key":"2025082800182475000_43.5.33.37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.1994.03510260078033","article-title":"A reevaluation of risk of in utero exposure to lithium","volume":"271","author":"Cohen","year":"1994","journal-title":"JAMA"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2005.43533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:18:37Z","timestamp":1756365517000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2005.43533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,5,1]]},"published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1136\/dtb.2005.43533"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2005.43533","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}